Clinical Study of Cardiomyopeptidin on Postoperative Ischemia-reperfusion Injury in Patients With Primary PCI

Clinical trial NCT03958422 · UNKNOWN

Trial details

NCT number: NCT03958422
Sponsor: Dalian Zhen-Ao Bio-Tech Co., Ltd.
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Survival Myocardial Area After Acute Myocardial Death Left Ventricular Ejection Fraction

Start date: 2019-06-01
Primary completion: 2019-11-30
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.